CIDRAP newsletters options
South Korea's government considers the hospital-linked outbreak over, as researchers reported on early vaccine and antibody findings.
Influenza activity is increasing in Australia, New Zealand, and South America, the World Health Organization (WHO) said in an update yesterday.
The Centers for Disease Control and Prevention (CDC) waited until last week to set a policy to centralize reporting of all lab mishaps within the agency despite previous high-profile lab accidents and promises of change, according to a USA Today story yesterday.
Vaccine efficacy was 60.3% for all ages but lower in kids under 9.
Germany is the second European country to report a recent highly pathogenic H7N7 outbreak in poultry.
Saudi Arabia's Ministry of Health (MOH) reported a new MERS-CoV case over the weekend and a death in a previously reported patient, both in Riyadh.
The new case involves a 30-year-old Saudi man who is hospitalized in stable condition, the MOH reported on Jul 25. He is not a healthcare worker but had contact with a MERS-CoV (Middle East respiratory syndrome coronavirus) patient in either a community or hospital setting, the MOH said.
Decades in the making, the world's first malaria vaccine was cleared by European regulators and awaits WHO decisions.
A report points to faulty inactivation of Bacillus anthracis spores and inadequate testing.
Researchers found that the World Health Organization (WHO) Ebola case definition has a specificity of only 31.5%, and they noted that 9% of Ebola patients reported neither a fever nor any Ebola risk exposure, calling into question WHO norms, according to a large study yesterday in The Lancet Infectious Diseases.
As Saudi Arabia's Minister of Health (MOH) today confirmed a new MERS-CoV case—the sixth in 4 days—a study found higher viral loads to be associated with more severe disease.
Money could come from governments, industry, and others, with grants monitored by independent groups.
BARDA's director says he's hopeful that a call for proposals in October will bear better fruit.
Middle East respiratory syndrome coronavirus (MERS-CoV) has sickened four more people in Saudi Arabia in the past 2 days, one of them fatally, according to reports from the country's Ministry of Health (MOH).
As the CDC orders a comprehensive review, the DoD blames a lack of scientific consensus for its release of live Bacillus anthracis.
With 26 new cases, much activity is centered in the two capitals for the 2nd week in a row.
Saudi Arabia's Ministry of Health (MOH) yesterday announced a new MERS-CoV case after going 4 days without one, and a study in macaques identified two drugs that might be candidate for human trials.
Two doses of H7N9 avian flu vaccine produced what is considered an adequate immune response in only 2% of adults vaccinated, but two different adjuvants boosted that rate to 57% and 84%, according to a study yesterday in the Journal of the American Medical Association (JAMA).
The contract is for bolstering monoclonal antibody treatment for Ebola.
China's Animal Disease Control Centre has confirmed H5N1 avian flu as the culprit in a die-off of more than 2,000 gulls at Qinghai Lake, a major migratory bird stopover site that has recorded large avian flu outbreaks in previous years, according to a report yesterday from the World Organization of Animal Health (OIE).
The top 10% of healthcare workers in terms of antibiotic use prescribe the drugs for 95% or more of patients they see for colds, bronchitis, or other acute respiratory infections (ARI), according to an Annals of Internal Medicine study yesterday.
The lowest 10%, in contrast, prescribe antibiotics at 40% or less of patient visits for ARI.
